Mendota Financial Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-981
Closed -$44K – 161
2024
Q4
$44K Buy
981
+978
+32,600% +$54.9K 0.03% 170
2024
Q3
$189 Sell
3
-296
-99% -$17.3K ﹤0.01% 652
2024
Q2
$17.7K Hold
299
– – 0.01% 212
2024
Q1
$23.8K Hold
299
– – 0.01% 210
2023
Q4
$23.6K Hold
299
– – 0.02% 236
2023
Q3
$20.9K Hold
299
– – 0.02% 172
2023
Q2
$20.7K Sell
299
-30
-9% -$2.13K 0.02% 173
2023
Q1
$33.3K Sell
329
-1
-0.3% -$84 0.03% 163
2022
Q4
$30.7K Buy
+330
New +$31.8K 0.04% 155

Other funds holding CVS

Mendota Financial Group's CVS Position: Q1 2025 in Review

Mendota Financial Group sold out of CVS Health (CVS) in Q1 2025, closing a stake of 981 shares — an estimated $44K sold.

Mendota Financial Group first reported a position in CVS in Q4 2022 and held it in 9 quarters. The position peaked at $44K in Q4 2024. 1,757 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Mendota Financial Group reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Mendota Financial Group sold 981 CVS Health shares in Q1 2025, an estimated $44K.
  • Mendota Financial Group first reported a position in CVS Health in Q4 2022 and held it in 9 quarters.
  • Mendota Financial Group's CVS Health position peaked at $44K in Q4 2024.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Mendota Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.